INSULET CORPORATION Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
INSULET CORPORATION (PODD) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2025-05-09
- INSULET CORPORATION adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2025-03-31 was $0.00.
- INSULET CORPORATION adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2021-12-31 was -$29.10M.
- INSULET CORPORATION adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2021-09-30 was -$41.70M.
- INSULET CORPORATION adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2021-06-30 was -$737.70M.
- INSULET CORPORATION adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2021 was -$808.50M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | |||
| 2021-12-31 | -$29.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$70.80M derived: sum of 2 quarters · filed 2024-02-23 | -$808.50M derived: sum of 3 quarters · filed 2024-02-23 | -$808.50M 10-K · filed 2024-02-23 |
| 2021-09-30 | -$41.70M 10-Q · filed 2022-11-04 | -$779.40M derived: sum of 2 quarters · filed 2022-11-04 | -$779.40M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | -$737.70M 10-Q · filed 2022-08-05 | -$737.70M 10-Q · filed 2022-08-05 | ||
| 2018-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$3.21M derived: sum of 2 quarters · filed 2019-11-06 | -$3.22M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | -$3.20M 10-Q · filed 2019-08-06 | -$3.21M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$12.00K 10-Q · filed 2019-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |